Financial Data and Key Metrics Changes - Adjusted earnings for Q1 2025 were $1.3 billion, or $1.96 per share, representing a 7% increase from the same period last year [11][24] - Adjusted return on equity was 14.4%, with a direct expense ratio of 12%, indicating operational efficiency [11][35] - Adjusted earnings were up 1% year-over-year, and 5% on a constant currency basis, driven by favorable life underwriting and higher variable investment income [24][25] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $367 million, up 29% year-over-year, attributed to favorable life underwriting margins due to lower mortality [12][25] - Retirement and Income Solutions (RIS) adjusted earnings totaled $400 million, with strong sales in synthetic GICs and UK longevity reinsurance, and inflows from pension risk transfers of $1.8 billion [13][27] - Asia adjusted earnings were $374 million, down 12% year-over-year, impacted by lower underwriting margins and higher taxes, although sales were up 10% [14][29] - Latin America adjusted earnings were $218 million, down 6% year-over-year, but up 7% on a constant currency basis, with adjusted PFOs up 1% reported and 14% constant currency [14][30] Market Data and Key Metrics Changes - The U.S. dollar has started to weaken against many currencies, which may benefit international business growth [7][9] - The company noted that the underlying growth of international businesses could emerge as a tailwind despite being masked by the strong dollar [9][12] Company Strategy and Development Direction - The company has rolled out a "New Frontier" strategy aimed at guiding operations over the next five years, focusing on strategic diversification and resilience [6][10] - A significant risk transfer deal was announced, reinsuring approximately $10 billion of U.S. retail variable annuity reserves, aimed at reducing enterprise risk [16][40] - The company is on a path to achieve $1 trillion in total assets under management for MetLife Investment Management [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the uncertain economic environment, emphasizing a recurring revenue business model [8][20] - The company is focused on executing its strategy without significant changes, despite rising recession risks [75][76] - Management highlighted strong fundamentals and a commitment to responsible growth and attractive returns [43] Other Important Information - The company returned approximately $1.8 billion to shareholders through dividends and share repurchases in Q1 2025 [17][36] - A new $3 billion share repurchase authorization was announced, reflecting confidence in financial strength [18][36] - The effective tax rate on adjusted earnings was 23.2%, slightly below the 2025 guidance range [33] Q&A Session Summary Question: Inquiry about spreads in the RIS business - Management acknowledged a sequential decline in spreads due to interest rate gaps and lower rates than expected, but noted growth momentum in the business [46][52] Question: Comments on the CRE portfolio and recovery indications - Management indicated that while there are signs of stabilization in the commercial mortgage loan book, ongoing uncertainty may impact momentum [56][58] Question: Discussion on the risk transfer deal valuation - Management explained that the deal was structured to reduce tail risk and was aligned with their economic valuation expectations, despite a loss in net income [63][67] Question: Underwriting experience in MetLife Holdings - Management reported that underwriting experience was consistent across both life insurance and long-term care segments [70][71] Question: Current environment's influence on capital management strategy - Management confirmed that while they are aware of the economic environment, their strategy remains focused on executing existing plans without significant changes [74][76] Question: Insights on PRT sales and market activity - Management noted that while market volatility can be a distraction, it does not significantly alter the pipeline for pension risk transfer transactions [90][91] Question: Expectations for variable investment income in 2025 - Management indicated that while Q1 results were strong, predicting future performance remains challenging due to market volatility [95][98]

Financial Data and Key Metrics Changes - The company reported adjusted earnings of $1,300,000,000 or $1.96 per share, up 7% from the same period a year ago, driven by favorable underwriting and good volume growth [11][24] - Adjusted return on equity in the first quarter was 14.4%, with a direct expense ratio of 12%, indicating efficiency [11][36] - Adjusted earnings were $1,300,000,000, up 1% year over year, and up 5% on a constant currency basis [24] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $367,000,000, up 29% from the prior year due to favorable life underwriting margins [12][25] - Retirement and Income Solutions (RIS) adjusted earnings totaled $400,000,000, with strong sales in synthetic GICs and UK longevity reinsurance [13][28] - Asia adjusted earnings were $374,000,000, down 12% year over year, primarily due to lower underwriting margins and higher taxes [13][30] - Latin America adjusted earnings were $218,000,000, down 6%, but up 7% on a constant currency basis [14][31] - EMEA adjusted earnings were $83,000,000, up 8% and up 14% on a constant currency basis [32] Market Data and Key Metrics Changes - The company noted that the U.S. dollar has started to weaken against many currencies, which could benefit international business growth [9][10] - The company experienced favorable life underwriting margins due to lower mortality rates in the working-age population, consistent with CDC data [12][26] Company Strategy and Development Direction - The company has rolled out its New Frontier strategy to guide operations over the next five years, focusing on strategic diversification and resilience [7][10] - A significant risk transfer deal was announced, reinsuring approximately $10,000,000,000 of U.S. Retail variable annuity and rider reserves, aimed at reducing enterprise risk [16][40] - The company aims to achieve $1,000,000,000,000 in total assets under management through MetLife Investment Management [17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the uncertain economic environment, emphasizing the all-weather nature of its business model [9][20] - The company is focused on executing its strategy without significant changes, despite rising recession risks [73][75] - Management highlighted strong underlying fundamentals and a commitment to responsible growth and attractive returns [43][44] Other Important Information - The company returned approximately $1,800,000,000 to shareholders through dividends and share repurchases in the first quarter [18][19] - The Board of Directors increased the common dividend per share by 4.1% [19] - The company ended the quarter with $4,500,000,000 in cash and liquid assets, above its target cash buffer [37][39] Q&A Session Summary Question: On spreads in the RIS business - Management acknowledged a sequential decline in spreads due to interest rate gaps and lower rates than expected, but noted growth momentum in the business [46][52][54] Question: On the commercial mortgage loan book - Management indicated that while there are signs of stabilization in real estate activity, uncertainty may slow momentum [56][58] Question: On the risk transfer deal valuation - Management explained that the deal was evaluated from multiple perspectives, including economic value and the removal of tail risk, which justified the transaction [62][66] Question: On underwriting experience in MetLife Holdings - Management reported that underwriting experience was in line with expectations across both life insurance and long-term care [68][69] Question: On capital management strategy in the current environment - Management confirmed that there would be no changes to capital management strategy, focusing on executing their existing strategy [72][75] Question: On PRT sales and market volatility - Management noted that while market volatility can be a distraction, it does not significantly impact the pipeline of transactions in the PRT space [87][90] Question: On variable investment income outlook - Management indicated that while the current environment poses challenges, they plan to provide preliminary information on expectations for variable investment income in July [94][96] Question: On the implementation of ESR in Japan - Management expressed confidence in operational readiness and indicated that the new framework would not change their operational approach [99][100]

1Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Table of contents | Topic | Page No. | | --- | --- | | Net income (loss) to adjusted earnings | 3 | | Adjusted earnings by segment and Corporate & Other (C&O) | 4 | | Variable investment income (VII) | 5 | | Direct expense ratio | 7 | | Cash & capital | 8 | | Vari ...

Group 1: Earnings Performance - MetLife reported quarterly earnings of $1.96 per share, missing the Zacks Consensus Estimate of $1.99 per share, but showing an increase from $1.83 per share a year ago, representing an earnings surprise of -1.51% [1] - The company posted revenues of $18.83 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.40%, compared to year-ago revenues of $17.02 billion [2] - Over the last four quarters, MetLife has surpassed consensus EPS estimates just once, while topping consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - MetLife shares have declined approximately 6.7% since the beginning of the year, compared to a decline of -5.5% for the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $2.30 on revenues of $18.55 billion, and for the current fiscal year, it is $9.11 on revenues of $74.94 billion [7] Group 3: Industry Context - The Insurance - Multi line industry, to which MetLife belongs, is currently ranked in the top 17% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact MetLife's stock performance [5] - The Zacks Rank for MetLife is currently 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6]

Financial Performance - Total revenues for Q1 2025 were $18,569 million, a slight decrease from $18,666 million in Q4 2024[5] - Net income attributable to MetLife, Inc. for Q1 2025 was $945 million, compared to $1,271 million in Q4 2024, reflecting a decrease of 25.6%[5] - Premiums, fees, and other revenues for Q1 2025 totaled $13,639 million, down from $14,475 million in Q4 2024[5] - Policyholder benefits and claims for Q1 2025 were $11,806 million, compared to $12,572 million in Q4 2024, indicating a decrease of 6.1%[5] - The company reported net investment income of $4,885 million for Q1 2025, down from $5,405 million in Q4 2024[5] - Total expenses for Q1 2025 were $17,215 million, a decrease from $17,285 million in Q4 2024[5] - The provision for income tax expense for Q1 2025 was $404 million, compared to $106 million in Q4 2024, showing an increase of 280.2%[5] - The adjusted earnings available to common shareholders for Q1 2025 were $879 million, compared to $1,239 million in Q4 2024, reflecting a decrease of 29.1%[5] - The company experienced net derivative losses of $432 million in Q1 2025, a significant recovery from losses of $903 million in Q4 2024[5] Year-to-Date Performance - Total revenues for the year-to-date period ended March 31, 2025, were $18,569 million, an increase from $16,057 million for the same period in 2024, representing a growth of 15.7%[13] - Adjusted net investment income for the year-to-date period ended March 31, 2025, was $5,213 million, compared to $5,068 million for the same period in 2024, reflecting an increase of 2.9%[13] - Adjusted premiums, fees, and other revenues for the year-to-date period ended March 31, 2025, were $13,614 million, up from $11,948 million for the same period in 2024, indicating a growth of 13.9%[14] - Total adjusted revenues for the year-to-date period ended March 31, 2025, reached $18,827 million, compared to $17,016 million for the same period in 2024, marking an increase of 10.6%[13] - Total expenses for the year-to-date period ended March 31, 2025, were $17,215 million, an increase from $15,012 million for the same period in 2024, representing a growth of 14.7%[14] - Total adjusted expenses for the year-to-date period ended March 31, 2025, were $16,985 million, compared to $15,185 million for the same period in 2024, reflecting an increase of 11.8%[14] Shareholder Metrics - Adjusted earnings available to common shareholders for Q1 2025 were $1,349 million, a decrease from $1,375 million in Q3 2024[18] - Group Benefits adjusted earnings available to common shareholders for Q1 2025 were $367 million, down from $416 million in Q4 2024[18] - The total equity of MetLife as of March 31, 2025, was $27,755 million, a slight increase from $27,703 million in Q4 2024[17] - The retained earnings increased to $43,131 million as of March 31, 2025, from $42,626 million in Q4 2024[17] Investment Performance - The company reported net investment losses of $375 million in Q1 2024, with net derivative losses of $979 million[6] - The yield on equity securities increased to 6.16% for the year-to-date period ended March 31, 2025, up from 5.48% in the previous year[51] - The ending carrying value of fixed maturity securities was $290,416 million as of March 31, 2025, compared to $279,855 million a year earlier[51] - The company reported investment portfolio gains (losses) of $(461) million for the year-to-date period ended March 31, 2025[51] Future Outlook - The company anticipates continued improvements in expense ratios and revenue growth as part of its future outlook[16] - Future guidance indicates adjusted earnings available to common shareholders, excluding notable items, is expected to remain stable around $1,349 million for Q1 2025[6] - The company plans to continue its strategy of share repurchases, with 16.9 million shares repurchased in Q1 2024[9] Operational Insights - MetLife continues to focus on enhancing its non-GAAP financial measures to provide better insights into its operational performance[4] - The company emphasizes the importance of non-GAAP financial measures to provide a clearer picture of operational performance and profitability drivers[1] - Adjusted earnings exclude the impact of market volatility and focus on core business performance, allowing for better comparisons to industry results[1]

Core Viewpoint - MetLife, Inc. is expected to report first-quarter 2025 results on April 30, with earnings estimated at $1.99 per share and revenues at $18.21 billion, reflecting year-over-year growth of 8.7% and 7% respectively [1] Financial Estimates - The Zacks Consensus Estimate for MetLife's revenues for the current year is $74.94 billion, indicating a year-over-year increase of 2.6% [2] - The consensus estimate for current-year EPS is $9.11, suggesting a year-over-year jump of approximately 12.33% [2] - In the last four quarters, MetLife beat the consensus estimate once, met it once, and missed twice, with an average surprise of negative 1.5% [2] Earnings Prediction - The current model does not predict a definitive earnings beat for MetLife, as it has an Earnings ESP of +0.24% but a Zacks Rank of 4 (Sell) [3][4] Factors Influencing Q1 Results - Rising adjusted group benefits revenues are anticipated to positively impact MetLife's first-quarter results, particularly from improved operations in international markets, especially Asia and Latin America [5] - The Zacks Consensus Estimate for total adjusted group benefits suggests a 2.3% increase from the prior-year quarter, driven by profits from Asia and Latin America [6] - Adjusted earnings from the domestic business are expected to grow by 10.5% year-over-year in the first quarter [7] Challenges - Rising costs and expenses may partially offset profit growth in the upcoming quarter, with net investment income consensus pegged at $5.3 billion, indicating a 3% decline year-over-year [9]

Core Insights - MetLife (MET) is expected to report quarterly earnings of $1.99 per share, reflecting an 8.7% increase year-over-year, with revenues projected at $18.21 billion, a 7% increase from the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 2.7% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenue- Premiums' to reach $10.97 billion, indicating a year-over-year increase of 9.1% [5]. - 'Revenue- Other Revenues' is expected to be $631.98 million, reflecting a decline of 6.2% year-over-year [5]. - 'Revenue- Universal life and investment-type product policy fees' is forecasted at $1.27 billion, showing a 1.7% increase from the prior year [5]. Investment Income and Regional Revenue - 'Revenue- Net investment income' is estimated at $5.27 billion, suggesting a decrease of 3.1% year-over-year [6]. - 'Total Adjusted Revenue- Latin America' is projected to be $1.95 billion, indicating a 3.4% increase year-over-year [6]. - 'Total Adjusted Revenue- U.S. Business' is expected to reach $10.64 billion, reflecting an 11.5% increase year-over-year [7]. Regional Adjusted Revenue - 'Total Adjusted Revenue- EMEA' is estimated at $703.80 million, indicating a 4.4% increase year-over-year [8]. - 'Total Adjusted Revenue- Asia' is projected to be $2.99 billion, reflecting a 4.8% increase year-over-year [8]. - 'Adjusted Revenue- Asia- Net investment income' is expected to reach $1.25 billion, indicating a 13% increase from the prior year [9]. Stock Performance - MetLife shares have decreased by 8.7% over the past month, compared to a 4.8% decline in the Zacks S&P 500 composite [10].

Core Insights - FTI Consulting, Inc. has expanded its Board of Directors by electing Eric T. Steigerwalt and Janet H. Zelenka as independent directors, increasing the board size from nine to eleven members [1] Group 1: New Board Members - Eric T. Steigerwalt, age 63, is the President and CEO of Brighthouse Financial, a major provider of annuities and life insurance in the U.S. [2] - Janet H. Zelenka, age 66, is the former Executive Vice President, CFO, and CIO of Stericycle, a company specializing in regulated medical waste disposal, which was acquired by WM in November 2024 [2][3] Group 2: Board Member Expertise - Mr. Steigerwalt brings extensive experience in operations, finance, and corporate culture, having held multiple senior roles at MetLife prior to his current position [3] - Ms. Zelenka has significant expertise in finance, IT, cybersecurity, governance, and corporate ethics, along with her experience as Audit Committee Chair on the boards of two private companies [5][6] Group 3: Company Overview - FTI Consulting is a leading global expert firm with over 8,300 employees across 34 countries, generating $3.69 billion in revenues during fiscal year 2024 [6]

Company Overview - HighPeak is an innovative, early-stage company leveraging AI technology, machine learning, and proprietary data to deliver accurate life planning data in the market [5] - The company is backed by Prudential Financial, a global financial services leader with approximately $1.5 trillion in assets under management as of December 31, 2024 [6] Leadership and Vision - Sharon Rodriguez, CEO of HighPeak, is leading efforts to transform financial planning for advisors by integrating healthcare costs, longevity insights, and financial risk analysis [1][2] - Rodriguez joined HighPeak in 2023 and has a multifaceted background as a corporate buyer, startup founder, and venture investor, equipping her to drive innovation and growth [3] Product and Technology - HighPeak provides an AI-powered platform that generates precise, real-time forecasts on healthcare costs, longevity, and financial risk, moving beyond traditional planning tools [2][4] - The platform aims to equip financial advisors with tools to anticipate future healthcare expenses confidently, enabling the creation of financial plans that reflect real-world health expenses [4] Market Strategy - HighPeak is focused on expanding partnerships and enhancing predictive capabilities to meet the growing demand for tailored financial planning solutions [4] - The company is launching solutions specifically designed for financial advisors, establishing a strong foundation for broader market expansion [3]

Core Viewpoint - MetLife's recent earnings report showed mixed results, with adjusted operating earnings per share (EPS) missing estimates but showing year-over-year growth. The company faces challenges in certain segments, particularly in the Group Benefits and Retirement and Income Solutions (RIS) units, while some areas like Asia performed well [2][3][9]. Financial Performance - Adjusted operating EPS for Q4 2024 was $2.08, missing the Zacks Consensus Estimate by 2.4%, but increased by 7.8% year over year [2]. - Adjusted operating revenues reached $19.7 billion, a 5.4% increase year over year, surpassing consensus estimates by 2.7% [2]. - Total expenses were $17.3 billion, down 4.4% year over year, attributed to lower interest credited to policyholder accounts and reduced interest expenses [5]. Segment Analysis - Group Benefits segment reported adjusted earnings of $416 million, down 11% year over year, but above the consensus estimate [7]. - RIS segment's adjusted earnings fell 8% year over year to $386 million, missing estimates due to reduced margins [8]. - Asia's adjusted earnings grew 50% year over year to $443 million, exceeding estimates, although adjusted PFOs declined by 4% [9]. - Latin America reported adjusted earnings of $201 million, a 3% decrease year over year, but a 10% increase on a constant currency basis [10]. - EMEA segment's adjusted earnings increased 26% year over year to $59 million, though it was below consensus estimates [11]. Capital and Equity - As of December 31, 2024, MetLife had cash and cash equivalents of $20.1 billion, a decline of 2.8% from the previous year [13]. - Total equity fell 8.4% year over year to $27.7 billion, with book value per share at $34.28, down 4.4% [14]. Future Outlook - Management anticipates variable investment income of $1.7 billion for 2025 and expects adjusted losses in the Corporate & Other segment to be between $850 million and $950 million [16]. - Over the next three years, adjusted PFOs in the Group Benefits business are projected to rise by 4-7%, while declines are expected in the MetLife Holdings segment [17]. - The company aims for an adjusted return on equity in the range of 15-17% and double-digit adjusted EPS growth in the near term [18]. Market Position - MetLife's stock has a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [22]. - The company is part of the Zacks Insurance - Multi line industry, which has seen varied performance among peers, such as Everest Group, which reported significant revenue growth but faced challenges in EPS [23][24].